Hi everyone!
Leukaemia Care are currently working with NICE as they decide whether to fund the use of gilteritinib (brand name Xospata) on the NHS. This is a drug for AML patients.
Whilst we can represent the views of AML patients as a whole, NICE like to hear from a patient who has had gilteritinib, or a family member or friend of someone who has had the drug.
If you would like to help us with this activity or would like more information, please get in touch by direct message on here, emailing advocacy@leukaemiacare.org.uk or call 01905 755977 and ask to speak to me.
Thanks,
Charlotte